| Literature DB >> 21151867 |
Zachary C Ruhe1, Christopher S Hayes.
Abstract
BACKGROUND: The tmRNA quality control system recognizes stalled translation complexes and facilitates ribosome recycling in a process termed 'ribosome rescue'. During ribosome rescue, nascent chains are tagged with the tmRNA-encoded SsrA peptide, which targets tagged proteins for degradation. In Escherichia coli, tmRNA rescues ribosomes arrested on truncated messages, as well as ribosomes that are paused during elongation and termination. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2010 PMID: 21151867 PMCID: PMC2998420 DOI: 10.1371/journal.pone.0015207
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1GalE is tagged with the SsrA peptide at several sites.
A) Schematic representation of the galE transcripts used in this study. GalE was produced from constructs with and without downstream galT́ coding sequence. His6-GalE variants were also expressed from related constructs encoding an N-terminal hexa-histidine (his) epitope tag. The intrinsic transcription terminator from the E. coli trp attenuator (trp-At) was introduced downstream of galE as described in the Methods. Northern blot probe binding sites and the positions of codon-192 and codon-338 truncations in the in vitro transcript standards are indicated. B) Western blot analysis of SsrA(DD) tagging. Whole-cell lysates from induced (+IPTG) and uninduced (-IPTG) cells were analyzed by Western blot using anti-SsrA(DD) polyclonal antibodies. The His6-GalE samples were purified by Ni2+-NTA affinity chromatography prior to analysis. Full-length GalE tagged at the C-terminus is indicated as GalE-SsrA(DD). C) Mass spectrometry of SsrA(His6)-tagged GalE. SsrA(His6)-tagged GalE chains were purified as described in Methods and analyzed by electrospray ionization-mass spectrometry. SsrA(His6) tagging occurs at positions corresponding to GalE residues Val127 – Leu154. The identified tagging clusters are presented schematically on the GalE chain. D) Northern blot analysis of galET́ and galE(trp-At) mRNA. Total RNA was isolated from tmRNA+ and ΔtmRNA cells and analyzed by Northern blot as described in Methods. The in vitro transcripts lane contains a mixture of two galE transcripts that are truncated at codon-192 and codon-338 of galE.
Figure 2His6-GalE tagging in RNase deletion strains.
A) Western blot analysis of SsrA(DD) tagging. His6-GalE was purified from cells expressing wild-type (RNase E+) or temperature sensitive RNase E(ts). His6-GalE was produced at the indicated temperatures as described in Methods. B) Northern blot analysis of tmRNA(DD). Total RNA was isolated from RNase E+ and RNase E(ts) cells incubated at the indicated temperatures. The migration positions of mature and pre-processed tmRNA(DD) are indicated. C) Western blot analysis of SsrA(DD) tagging. His6-GalE was purified from tmRNA(DD) cells deleted for the indicated RNases, and analyzed by Western blot using anti-SsrA(DD) polyclonal antibodies. The Δtoxin-5 strain lacks RelE, MazF, ChpBK, YafQ, and YoeB toxins. Western blot analysis was also performed on His6-GalE purified from tmRNA(DD) cells lacking the Lon protease.
Figure 3Overproduction of 3′-to-5′ exoribonucleases has no effect on His6-GalE tagging.
A) Northern blot analysis of his mRNA. RNA was isolated from ΔtmRNA cells overproducing RNase II, PNPase, or RNase R from a plasmid-borne arabinose inducible promoter. Negative control RNA was isolated from cells carrying the plasmid pCH450 vector. The migration positions of in vitro transcripts truncated at codons-192 and -338 are indicated. B) Western blot analysis of SsrA(DD) tagging. His6-GalE was purified from tmRNA(DD) cells overproducing the indicated exonucleases, and analyzed by Western blot using anti-SsrA(DD) polyclonal antibodies. The negative control sample contains His6-GalE isolated from tmRNA(DD) cells carrying the plasmid pCH450 vector.
Figure 4Codon usage, ribosome queuing and SsrA tagging.
His6-GalE chains were purified from tmRNA(DD) cells and analyzed by Western blot using anti-SsrA(DD) polyclonal antibodies. The His6-GalE(recode) protein was expressed from a construct in which the last 170 codons had been synonymously recoded to change the mRNA sequence, but not the protein sequence (see Fig. S1). His6-GalE(AK) contains two additional residues (Ala-Lys) at its C-terminus. His6-GalE chains in the lanes labeled P and P were synthesized from bacteriophage T7 and E. coli RNA polymerase expression systems, respectively.
Figure 5SsrA tagging of GalE-TrxA fusion proteins.
A) Schematic representation of GalE, TrxA, and protein fusions. Also shown are SsrA(DD)-tagged standard proteins that were used as molecular markers for the gel analyses shown in panel B. SsrA(DD) tags were encoded at the indicated positions (downward arrows). B) Western blot analysis of SsrA(DD) tagging. N-terminally His6-tagged proteins were purified from tmRNA(DD) cells, and analyzed by Western blot using anti-SsrA(DD) polyclonal antibodies. Lanes loaded with SsrA(DD)-tagged standard proteins are indicated (STD). The lower panel shows a Coomassie stained polyacrylamide gel to show protein loading. C) Schematic representation of SsrA peptide tagging sites on GalE and fusion proteins. Amino acid residues and protein regions depicted in red indicate the sites of SsrA(His6) peptide tagging determined by mass spectrometry (see Supplemental data). Numbered residues correspond to the GalE primary sequence. Regions colored in yellow and light green indicate GalE and TrxA domains, respectively.
Bacterial strains used in this study.
|
|
|
|
| CH12 | X90 (DE3) |
|
| CH113 | X90 (DE3) |
|
| CH2182 | CH12 |
|
| CH2316 | CH12 |
|
| CH2385 | CH12 |
|
| CH3136 | X90 (DE3) Δ | This study & |
| CH3138 | CH2385 | This study & |
| CH3139 | CH2385 | This study & |
| CH3153 | CH2385 | This study & |
| CH3545 | CH2385 | This study & |
| CH3546 | CH2385 | This study & |
| CH3547 | CH2385 | This study & |
| CH3566 | CH2385 | This study & |
| CH6080 | CH2385 | This study & |
Abbreviations used: chloramphenicol resistant, Cmr; kanamycin resistant, Kanr.
Plasmids used in this study.
|
|
|
|
| pGalET́ | pET21b-derived plasmid expressing GalE, Ampr | This study |
| pGalE(trp-At) | pET21b-derived plasmid containing the | This study |
| pHis6-GalE | pET21b-derived plasmid expressing His6-GalE, Ampr | This study |
| pHis6-GalE(trp-At) | pET21b-derived plasmid containing the | This study |
| pHis6-GalE(recode) | pET21b-derived plasmid expressing His6-GalE from recoded | This study |
| pHis6-GalE(AK) | pET21b-derived plasmid expressing His6-GalE with C-terminal Ala-Lys extension, Ampr | This study |
| pBAD-His6-GalE | pBAD24-derived plasmid expressing His6-GalE, Ampr | This study & |
| pHis6-TrxA | pET21b-derived plasmid expressing His6-TrxA, Ampr | This study |
| pHis6-GalE(1–180)-TrxA | pET21b-derived plasmid expressing His6-GalE(1–180)-TrxA, Ampr | This study |
| pHis6-TrxA-GalE(180–338) | pET21b-derived plasmid expressing His6-TrxA-GalE(180–338), Ampr | This study |
| pCH450 | pACYC184-derived plasmid containing |
|
| pRNase II | pCH450-derived plasmid expressing RNase II under control of ParaBAD, Tetr |
|
| pPNPase | pCH450-derived plasmid expressing PNPase under control of ParaBAD, Tetr |
|
| pRNase R | pCH450-derived plasmid expressing RNase R under control of ParaBAD, Tetr |
|
| pRARE | pACYC184-derived plasmid expressing | Novagen |
| pHis6-GalE(1–141)-SsrA(DD) | pET21b-derived plasmid expressing His6-GalE(1–141)-SsrA(DD), Ampr | This study |
| pHis6-GalE(1–193)-SsrA(DD) | pET21b-derived plasmid expressing His6-GalE(1–193)-SsrA(DD), Ampr | This study |
| pHis6-GalE(1–337)-SsrA(DD) | pET21b-derived plasmid expressing pHis6-GalE(1–337)-SsrA(DD), Ampr | This study |
| pHis6-GalE(1–180)-TrxA(1–12)-SsrA(DD) | pET21b-derived plasmid expressing His6-GalE(1–180)-TrxA(1–12)-SsrA(DD), Ampr | This study |
| pHis6-TrxA-GalE(180–193)-SsrA(DD) | pET21b-derived plasmid expressing His6-TrxA-GalE(180–193)-SsrA(DD), Ampr | This study |
| pHis6-TrxA-GalE(180–337)-SsrA(DD) | pET21b-derived plasmid expressing His6-TrxA-GalE(180–337)-SsrA(DD), Ampr | This study |
| pHis6-TrxA-SsrA(DD) | pET21b-derived plasmid expressing His6-TrxA-SsrA(DD), Ampr | This study |
Abbreviations used: ampicillin resistant, Ampr; chloramphenicol resistant, Cmr; tetracycline resistant, Tetr.